Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Andersson, M. I.
Right arrow Articles by MacGowan, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, M. I.
Right arrow Articles by MacGowan, A. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 429-430
© 2002 The British Society for Antimicrobial Chemotherapy

Correspondence

Trends in original research published from the United Kingdom in the antimicrobial literature

M. I. Andersson and A. P. MacGowan,*

Department of Medical Microbiology, Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust and University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK

Sir,

There is increasing concern about the problems of antimicrobial resistance. In the words of the House of Lords' report published in 1998, ‘Resistance to antibiotics ... constitutes a major threat to public health and ought to be recognized as such more widely than at present’.1 Despite this, there is a feeling that the UK's contribution to the science of antimicrobial chemotherapy is still in decline. Five years ago a systematic review looking at the . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?